AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
AIBOTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00+0.00 (+42.86%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Aibotics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Aibotics filed with the SEC
PRESS RELEASE ANNOUNCING ACQUISITION OF ASSETS FROM PHILON LABS LLC
Material agreement · Acquisition or disposition completed · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ANNOUNCING TERMINATION OF AGREEMENT AND PLAN OF MERGER
Agreement terminated · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ANNOUNCING AGREEMENT AND PLAN OF MERGER
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K